Ixekizumab (Anti-CTLA-8 / IL-17a)

Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

• Supplier: Selleck Chemicals
• Product #: A2862
• Sku #: A2862-1mg*25